Douglas Tremblay

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Acute Myeloid Leukemia

Ejection Fraction

Combination Therapy

Top Venues

Current treatment options in oncology

European journal of haematology

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Douglas Tremblay, Nicole E Wagner, John Mascarenhas
Management of Advanced Systemic Mastocytosis: Clinical Challenges. Journal of blood medicine 15 (2024)
Douglas Tremblay, Ruben Mesa
New Treatments for Myelofibrosis. Current treatment options in oncology 24 (2) (2023)
Douglas Tremblay, Ruben Mesa
New Treatments for Myelofibrosis. Current treatment options in oncology 24 (2) (2023)
Dahniel Sastow, Douglas Tremblay
Emerging Treatment Options for Myelofibrosis: Focus on Anemia. Therapeutics and clinical risk management 19 (2023)
Douglas Tremblay, Dahiel Sastow, John O Mascarenhas
CNL and aCML are prognostically distinct: a large national cancer database analysis. Blood advances (2023)
Douglas Tremblay, Ruben Mesa
New Treatments for Myelofibrosis. Current treatment options in oncology 24 (2) (2023)
Douglas Tremblay, Ruben Mesa
New Treatments for Myelofibrosis. Current treatment options in oncology 24 (2) (2023)
Douglas Tremblay, Ruben Mesa
New Treatments for Myelofibrosis. Current treatment options in oncology (2023)
Serena Tharakan, John O Mascarenhas, Douglas Tremblay
Understanding triple negative myeloproliferative neoplasms: pathogenesis, clinical features, and management. Leukemia & lymphoma (2023)
Yosef Joseph Rene Amel Riazat-Kesh, Alexander Maraveyas, Lily Martin, Douglas Tremblay
An overlooked mimic? Autoimmune myelofibrosis-A scoping review of the literature. European journal of haematology (2023)
Hannah Goulart, John Mascarenhas, Douglas Tremblay
Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions. Annals of hematology 101 (5) (2022)
Douglas Tremblay, Ruben A Mesa
Momelotinib for the treatment of myelofibrosis with anemia. Future oncology (London, England) 18 (20) (2022)
Julian A Waksal, Douglas Tremblay, John Mascarenhas
Clinical Utility of Fedratinib in Myelofibrosis. OncoTargets and therapy 14 (2021)
Douglas Tremblay, Noa Rippel, Jonathan Feld, Siraj M El Jamal, John Mascarenhas
Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia. The oncologist 26 (5) (2021)
John Yohan Rhee, Douglas Tremblay, Amy M Chan, Martin S Tallman, John O Mascarenhas
Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review. Blood advances 3 (12) (2020)
Douglas Tremblay, Carina Seah, Thomas Schneider, Sheena Bhalla, Jonathan Feld, Leonard Naymagon, Bo Wang, Vaibhav Patel, Tomi Jun, Thomas Jandl, Farah Rahman, Sean T H Liu, Judith A Aberg, Nicole Bouvier, null null
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients. Cancer medicine 9 (22) (2020)
Leonard Naymagon, Douglas Tremblay, Kevin Troy, John Mascarenhas
Soluble interleukin-2 receptor (sIL-2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis. European journal of haematology 105 (3) (2020)
Frans Beerkens, Mira John, Benjamin Puliafito, Virginia Corbett, Colleen Edwards, Douglas Tremblay
COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient. American journal of hematology 95 (7) (2020)
Douglas Tremblay, Alexander S Vogel, Erin Moshier, Ronald Hoffman, Marina Kremyanskaya, Selena Zhou, Thomas Schiano, John Mascarenhas
Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience. European journal of haematology 104 (1) (2019)
Douglas Tremblay, Juan Putra, Alexander Vogel, Adam Winters, Ronald Hoffman, Thomas D Schiano, Maria Isabel Fiel, John O Mascarenhas
The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib. Case reports in hematology 2019 (2019)